ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag neglected tropical diseases disease medicine developmental biology genetics genomics

An Orphan Disease Gets Adopted
Steve Bunk | Nov 12, 2000 | 7 min read
Courtesy of Ed Rowton, Walter Reed Army Institute of Research An anopheline mosquito taking a blood meal. Researchers and physicians, open your guides to rare diseases, for that may be the only place you'll encounter Jumping Frenchmen of Maine. There you also will find Kabuki Make-up Syndrome, Split-Hand Deformity, Stiff Person Syndrome, Tangier Disease, and Twin-Twin Transfusion Syndrome. These are among thousands of "orphan diseases," originally so called because they weren't "adopted" by spon
AIDS Pandemic Provokes Alarming Reassessments Of Infectious Disease
Joshua Lederberg | Jul 11, 1993 | 5 min read
In 1900, infectious disease was the leading cause of mortality in the United States, accounting for at least 37 percent of deaths. By 1950, this had been mitigated to 6.8 percent and, by 1989, to 2.8 percent, with corresponding improvements in life expectancy. These numbers, of course, must be taken with a grain of salt, given the eventual preemptive role of infection in chronic illness, and many disorders whose infectious etiology is still to be recognized. Further, the relative importance
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
CRISPR Can Track Cellular History of a Mammalian Embryo
Sukanya Charuchandra | Aug 10, 2018 | 2 min read
Researchers used the genome-editing technology to analyze the development of mouse tissues.
Forging a Palace for Research on Aging
Eugene Russo | Feb 4, 2001 | 9 min read
Graphic: Cathleen Heard No one can escape one of the few risk factors common to neurodegenerative diseases, heart disease, and many cancers: age. Within the last decade or so, research on aging, once seen as unfeasible and impractical, has become the legitimate purview of many scientists who hope to prolong life, improve quality of later life, and delay humans' decay at the cellular and genetic level. By viewing aging as a fundamental root of other diseases, researchers studying the mechanisms
Syphilis: Then and Now
Kristin N Harper, George J. Armelagos, and Molly K. Zuckerman | Feb 1, 2014 | 10+ min read
Researchers are zeroing in on the origin of syphilis and related diseases, which continue to plague the human population some 500 years after the first documented case.
The AIDS Research Evaluators
Lynn Gambale | Jul 9, 1995 | 6 min read
Chairman: Arnold Levine, chairman, department of molecular biology, Princeton University Barry Bloom, Weinstock Professor and Howard Hughes Medical Institute (HHMI) investigator, department of microbiology and immunology, Albert Einstein College of Medicine, New York Rebecca Buckley, professor of pediatrics and immunology, Duke University Medical Center Charles Carpenter, chairman, Office of AIDS Research Advisory Committee; professor of medicine,Brown University School of Medicine Don
Prospecting for Gold in Genome Gulch
Amy Adams | Apr 14, 2002 | 9 min read
The human genome is much like the American West of the 1850s: Everyone wants a piece of the pie. Similar to gold prospectors of 150 years ago, biotech and pharmaceutical companies, and even universities, are frantically searching for the nuggets of gold that will help them find the mother lode—a gene whose function is sufficiently marketable to make all of the preliminary research worthwhile. Companies that do strike gold get to introduce new classes of drugs to the market. Others hope to
The Rodent Wars: Is a Rat Just a Big Mouse?
Ricki Lewis | Jul 4, 1999 | 5 min read
Sometimes it seems as if genome projects are cropping up everywhere.1 But until costs come down, limited resources are being largely concentrated into what Joseph Nadeau, professor of genetics at Case Western Reserve University School of Medicine, calls "the genome seven," an apples-and-oranges list of viruses, bacteria, fungi, Arabidopsis thaliana, Drosophila melanogaster, Caenorhabditis elegans, and mouse, with Homo sapiens in its own category.2 Researchers widely acknowledge that in the rod

Run a Search

ADVERTISEMENT